On-Demand Webinar: Proven Strategies for Preclinical Manufacturing and Early Process Development
Avi Nandi, Chief Technical Officer and Tatiana Nanda, Head of Cell Therapy Process Development
While the rigors of early process development (PD) and preclinical manufacturing in cell and gene therapy can appear daunting for product developers, focusing on the quality of pre-clinical study design and material can mean the difference between success and failure for these highly sensitive drug products during clinical trials and commercial launch.
CBM experts, Avi Nandi, Chief Technical Officer and Tatiana Nanda Sr. Director, Drug Product share how a strategic approach to early-stage process development studies and pilot plant scale-up techniques can advance your program to first time right cGMP production.
In this webinar learn:
- – How key early-stage studies can mitigate risk and prepare companies for successful regulatory submissions
- – How high-throughput capabilities are available to improve process productivity and scalability
- – Why Pilot Plant operations provide flexibility and training advantages for preclinical production
In need of immediate assistance for your advanced therapy product? Simply call to speak with a CBM expert: 866-274-4009.